Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients

Analytical performance of the FDA-cleared Parsortix®PC1 system

Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix®PC1 System

Comparison of microfuidic platforms for the enrichment of circulating tumor cells in breast cancer patients

Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions

The metastatic spread of breast cancer accelerates during sleep

An in vivo CRISPR screen identifies stepwise genetic dependencies of metastatic progression

Microtubule disruption reduces metastasis more effectively than primary tumor growth

Request a meeting with